Ahammed Nizar O T, Rai Pratheeksha, Rao Shobhana Nayak, Shenoy M Pradeep
Department of Internal Medicine, K.S. Hegde Medical Academy, Mangalore, Karnataka, India.
Department of Nephrology, K.S. Hegde Medical Academy, Mangalore, Karnataka, India.
Indian J Crit Care Med. 2017 Dec;21(12):857-860. doi: 10.4103/ijccm.IJCCM_177_17.
The term plasmapheresis/plasma exchange refers to the removal of the plasma component of blood and its replacement with various fluids. Plasma Exchange (PE) has been used to treat a variety of conditions that are associated with an aberrant immune response. We undertook this retrospective study aiming to look at plasmapheresis procedures conducted in the nephrology department over a fixed time period.
Retrospective analysis of PE procedures from January 2013 to October 2016 was conducted in the nephrology and Intensive Care Unit of a tertiary care teaching hospital. The goal was to achieve a total removal of 150-200 ml/plasma per kg body weight. As replacement, we used a standard protocol of 100 ml of 20% albumin in 1 L of normal saline and 2-3 units of fresh frozen plasma. All results were expressed as mean ± standard deviation and statistical analysis was done using the Student's -test for continuous and Fisher's exact test for categorical data.
A total of 192 procedures performed on 40 patients (22 males and 18 females). Age ranged from 15 to 79 years with a mean age of 37.5 years. Guillain-Barre syndrome accounted for 67.5% (>two-third of causes) for PE. Vascular access was femoral catheter in 27 (67.5%) and internal jugular catheter in 13 (32.5%). Mild hypotension occurred in 15 procedures (7.8%) of patients and allergic reactions such as rashes and chills occurred in 5 cycles (2.6%). A total of 36 patients (90%) showed significant improvement in condition, 2 did not show any change, while one worsened and one died due to respiratory complications.
Our small series of data of plasmapheresis procedures from nephrology perspective has reaffirmed the safety and efficacy of the therapy in an experienced setup.
血浆置换/血浆分离术是指去除血液中的血浆成分并用各种液体进行置换。血浆置换(PE)已被用于治疗多种与异常免疫反应相关的病症。我们进行了这项回顾性研究,旨在观察在固定时间段内科肾病科进行的血浆置换程序。
对一家三级护理教学医院的肾病科和重症监护病房2013年1月至2016年10月期间的血浆置换程序进行回顾性分析。目标是实现每公斤体重总共去除150 - 200毫升血浆。作为置换液,我们使用了在1升生理盐水中加入100毫升20%白蛋白和2 - 3单位新鲜冰冻血浆的标准方案。所有结果均表示为平均值±标准差,采用学生t检验对连续数据进行统计分析,采用Fisher精确检验对分类数据进行统计分析。
共对40例患者(22例男性和18例女性)进行了192次血浆置换程序。年龄范围为15至79岁,平均年龄为37.5岁。格林 - 巴利综合征占血浆置换原因的67.5%(超过三分之二)。血管通路为股静脉导管的有27例(67.5%),颈内静脉导管的有13例(32.5%)。15例患者的置换程序(7.8%)出现轻度低血压,5个周期(2.6%)出现皮疹和寒战等过敏反应。共有36例患者(90%)病情有显著改善,2例无变化,1例病情恶化,1例因呼吸并发症死亡。
我们从肾病学角度对血浆置换程序的小系列数据再次证实了该疗法在经验丰富的环境中的安全性和有效性。